Novartis Ag (NVS) Invested Capital (2009 - 2026)

Novartis Ag has disclosed Invested Capital across 18 years of filings, most recently posting $51.5 billion for Q2 2026.

• In Q2 2026, Invested Capital rose 2.31% year-over-year to $51.5 billion; the TTM figure through Jun 2026 stood at $51.5 billion (up 2.31% YoY), while the FY2025 annual figure was $52.8 billion, changed 0.32% from the prior year.
• Invested Capital came in at $51.5 billion for Q2 2026 at Novartis Ag, up from $46.5 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $70.1 billion in Q2 2022 to a low of $43.7 billion in Q3 2023.
• Average Invested Capital over 5 years is $55.0 billion, with a median of $52.6 billion recorded in 2025.
• Year-over-year, Invested Capital sank 35.69% in 2023 and rose 14.42% in 2024.
• Over 5 years, Invested Capital stood at $66.2 billion in 2022, then dropped by 19.13% to $53.5 billion in 2023, then decreased by 1.03% to $53.0 billion in 2024, then retreated by 0.32% to $52.8 billion in 2025, then decreased by 2.46% to $51.5 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $51.5 billion in Q2 2026, $46.5 billion in Q1 2026, and $52.8 billion in Q4 2025.